These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19524457)

  • 1. Early detection of local RFA site recurrence using total liver volume perfusion CT initial experience.
    Meijerink MR; van Waesberghe JH; van der Weide L; van den Tol P; Meijer S; Comans EF; Golding RP; van Kuijk C
    Acad Radiol; 2009 Oct; 16(10):1215-22. PubMed ID: 19524457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
    Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
    Kawamura Y; Ikeda K; Seko Y; Hosaka T; Kobayashi M; Saitoh S; Kumada H
    AJR Am J Roentgenol; 2011 Oct; 197(4):W665-73. PubMed ID: 21940538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases.
    Meijerink MR; van Waesberghe JH; van der Weide L; van den Tol P; Meijer S; van Kuijk C
    Eur Radiol; 2008 Oct; 18(10):2345-54. PubMed ID: 18491094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of effects of motion compensation for liver and lung tumors in CT perfusion.
    Bevilacqua A; Barone D; Malavasi S; Gavelli G
    Acad Radiol; 2014 Nov; 21(11):1416-26. PubMed ID: 25300721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value or waste: Perfusion imaging following radiofrequency ablation - early experience.
    Thieme SF; Vahldiek JL; Tummler K; Poch F; Gemeinhardt O; Hiebl B; Lehmann KS; Hamm B; Niehues SM
    Clin Hemorheol Microcirc; 2015; 61(2):323-31. PubMed ID: 26410879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
    Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-D Imaging in cerebrovascular disorders by using 320-slice CT: feasibility and preliminary clinical experience.
    Klingebiel R; Siebert E; Diekmann S; Wiener E; Masuhr F; Wagner M; Bauknecht HC; Dewey M; Bohner G
    Acad Radiol; 2009 Feb; 16(2):123-9. PubMed ID: 19124096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT perfusion of renal cell carcinoma: impact of volume coverage on quantitative analysis.
    Reiner CS; Goetti R; Eberli D; Klotz E; Boss A; Pfammatter T; Frauenfelder T; Moch H; Sulser T; Alkadhi H
    Invest Radiol; 2012 Jan; 47(1):33-40. PubMed ID: 21730874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of Preinterventional MR Imaging With Liver Perfusion CT After RFA of Hepatocellular Carcinoma: Early Quantitative Prediction of Local Recurrence.
    Kobe A; Kindler Y; Klotz E; Puippe G; Messmer F; Alkadhi H; Pfammatter T
    Invest Radiol; 2021 Mar; 56(3):188-196. PubMed ID: 32932379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-energy CT in assessing therapeutic response to radiofrequency ablation of renal cell carcinomas.
    Park SY; Kim CK; Park BK
    Eur J Radiol; 2014 Feb; 83(2):e73-9. PubMed ID: 24345460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative computed tomography liver perfusion imaging using dynamic spiral scanning with variable pitch: feasibility and initial results in patients with cancer metastases.
    Goetti R; Leschka S; Desbiolles L; Klotz E; Samaras P; von Boehmer L; Stenner F; Reiner C; Stolzmann P; Scheffel H; Knuth A; Marincek B; Alkadhi H
    Invest Radiol; 2010 Jul; 45(7):419-26. PubMed ID: 20498611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric arterial enhancement fraction predicts tumor recurrence after hepatic radiofrequency ablation of liver metastases: initial results.
    Mahnken AH; Klotz E; Schreiber S; Bruners P; Isfort P; Günther RW; Wildberger JE
    AJR Am J Roentgenol; 2011 May; 196(5):W573-9. PubMed ID: 21512047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth rate of new hepatocellular carcinoma after percutaneous radiofrequency ablation: evaluation with multiphase CT.
    Park Y; Choi D; Lim HK; Rhim H; Kim YS; Kim SH; Lee WJ
    AJR Am J Roentgenol; 2008 Jul; 191(1):215-20. PubMed ID: 18562748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A feasibility study: evaluation of radiofrequency ablation therapy to hepatocellular carcinoma using image registration of preoperative and postoperative CT.
    Fujioka C; Horiguchi J; Ishifuro M; Kakizawa H; Kiguchi M; Matsuura N; Hieda M; Tachikake T; Alam F; Furukawa T; Ito K
    Acad Radiol; 2006 Aug; 13(8):986-94. PubMed ID: 16843851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET-CT after radiofrequency ablation of colorectal liver metastases: suggestions for timing and image interpretation.
    Nielsen K; van Tilborg AA; Scheffer HJ; Meijerink MR; de Lange-de Klerk ES; Meijer S; Comans EF; van den Tol MP
    Eur J Radiol; 2013 Dec; 82(12):2169-75. PubMed ID: 24021269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.
    Donckier V; Van Laethem JL; Goldman S; Van Gansbeke D; Feron P; Ickx B; Wikler D; Gelin M
    J Surg Oncol; 2003 Dec; 84(4):215-23. PubMed ID: 14756432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT hepatic perfusion measurement: comparison of three analytic methods.
    Kanda T; Yoshikawa T; Ohno Y; Kanata N; Koyama H; Takenaka D; Sugimura K
    Eur J Radiol; 2012 Sep; 81(9):2075-9. PubMed ID: 21802233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation of liver tumors: quantitative assessment of tumor coverage through CT image processing.
    Passera K; Selvaggi S; Scaramuzza D; Garbagnati F; Vergnaghi D; Mainardi L
    BMC Med Imaging; 2013 Jan; 13():3. PubMed ID: 23324557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-rigid registration of the liver in consecutive CT studies for assessment of tumor response to radiofrequency ablation.
    Niculescu G; Foran DJ; Nosher J
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():856-9. PubMed ID: 18002091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.